Locations:
Search IconSearch

Cancer

pancreas
January 13, 2023/Cancer

Case Study: Main Duct Intraductal Papillary Mucinous Neoplasm Treated with Total Pancreatectomy and Chemotherapy

Pancreas and spleen removed to minimize risk of pancreatic cancer

Bladder mass
January 11, 2023/Cancer

Case Study: Child with Embryonal Rhabdomyosarcoma Undergoes Cystoprostatectomy and Ileal Conduit Urinary Diversion

A recent case study illustrates surgical intervention for treating recurrent bladder cancer

Breast cancer
January 4, 2023/Cancer/Research

Invasive Lobular Cancer and Invasive Ductal Cancer Require Different Clinical Management

Patients with ER-positive invasive lobular cancer face worse disease-free survival and overall survival

22-NEU-3409069-CQD-Hero-650×450
December 20, 2022/Cancer

Survival Is Associated With Subsets of T Cells in Recurrent Glioblastoma Treated With SL-701

Can T-cell immunophenotyping help inform treatment decisions?

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

22-CNR-3423058-CQD-Hero-650×450 Dr Moore
December 20, 2022/Cancer/Research

Stopping Hormone Therapy for Pregnancy in Patients with Hormone-Receptor Positive Breast Cancer

First prospective study looks at endocrine therapy interruption in premenopausal patients

Lab research
December 16, 2022/Cancer/Research

Researchers Identify Risk Factors of Secondary Malignancy in Breast Cancer Survivors

Prior history of autoimmunity and solid organ transplantation significantly increases chance of myelodysplastic syndrome or acute myeloid leukemia

22-DDI-3242262 – Neuroendocrine Tumor-Kim-3-hero
December 15, 2022/Cancer

Neuroendocrine Tumors: Today’s GIs Likely Will Encounter Them

Cleveland Clinic program to streamline clinical care and research

Dr. Brian T. Hill
December 14, 2022/Cancer/Research

Precision Medicine Approach Needed to Treat Subgroups of Diffuse Large B-Cell Lymphoma

Distinct molecular features found in five subtypes of disease

CAR T-cells
December 13, 2022/Cancer/Research

Study Provides Insights about Chemorefractory Diffuse Large B-Cell Lymphoma

Patients who relapse early after first-line chemotherapy are often, but not always, refractory to second-line chemotherapy

BackPage 30 of 86Next

Advertisement

Ad